Andrew McKibben | Vice President, Investor Relations and Finance |
Chris Peetz | President and Chief Executive Officer |
Ian Clements | Chief Financial Officer |
Peter Radovich | Chief Operating Officer |
Pamela Vig | Head of R&D |
Jessica Fye | JPMorgan |
Mani Foroohar | SVB Securities |
Josh Schimmer | Evercore |
Ryan Deschner | Raymond James |
David Lebowitz | Citi |
Brian Skorney | Baird |
Ed Arce | H.C. Wainwright |
Yasmeen Rahimi | Piper Sandler |
Good afternoon. Thank you for attending the Mirum Pharmaceuticals Fourth Quarter and Year-End 2022 Financial Results and Business Update. My name is Matt, and I'll be your moderator for today's call. [Operator Instructions].
I'll now like to turn the conference over to our host, Andrew McKibben, Vice President of the Investor Relations and Finance.